Raymond James Financial Services Advisors, Inc. Sanofi Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Sanofi stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 109,658 shares of SNY stock, worth $5.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

109,658

Previous 163,285 32.84%

Holding current value

$5.35 Million

Previous $7.92 Million 20.2%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$48.54 - $58.53 $2.6 Million - $3.14 Million	-53,627 Reduced 32.84%	109,658 $6.32 Million
Q2 2024 Jul 19, 2024	BUY	$45.39 - $50.36 $291,040 - $322,908	6,412 Added 4.09%	163,285 $7.92 Million
Q1 2024 Apr 22, 2024	SELL	$45.75 - $52.48 $1.01 Million - $1.16 Million	-22,130 Reduced 12.36%	156,873 $7.62 Million
Q4 2023 Jan 16, 2024	SELL	$43.13 - $54.79 $1.77 Million - $2.25 Million	-41,023 Reduced 18.64%	179,003 $8.9 Million
Q3 2023 Oct 24, 2023	BUY	$50.95 - $55.2 $2.59 Million - $2.81 Million	50,882 Added 30.08%	220,026 $11.8 Million
Q2 2023 Jul 25, 2023	SELL	$50.45 - $57.18 $455,311 - $516,049	-9,025 Reduced 5.07%	169,144 $9.12 Million
Q1 2023 Apr 14, 2023	BUY	$45.86 - $54.45 $482,493 - $572,868	10,521 Added 6.28%	178,169 $9.7 Million
Q4 2022 Feb 08, 2023	SELL	$38.86 - $48.55 $1.12 Million - $1.4 Million	-28,801 Reduced 14.66%	167,648 $8.12 Million
Q3 2022 Oct 25, 2022	BUY	$37.22 - $100.5 $1.98 Million - $5.36 Million	53,289 Added 37.22%	196,449 $7.47 Million
Q2 2022 Aug 12, 2022	BUY	$48.99 - $57.46 $1.54 Million - $1.8 Million	31,336 Added 28.02%	143,160 $7.16 Million
Q1 2022 May 11, 2022	BUY	$48.48 - $53.65 $158,723 - $175,650	3,274 Added 3.02%	111,824 $5.74 Million
Q4 2021 Feb 08, 2022	BUY	$47.07 - $52.35 $663,028 - $737,402	14,086 Added 14.91%	108,550 $5.44 Million
Q3 2021 Nov 02, 2021	BUY	$47.89 - $53.12 $93,002 - $103,159	1,942 Added 2.1%	94,464 $4.55 Million
Q2 2021 Aug 11, 2021	SELL	$49.36 - $54.25 $125,473 - $137,903	-2,542 Reduced 2.67%	92,522 $4.87 Million
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $320,493 - $356,095	7,050 Added 8.01%	95,064 $4.7 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $41,177 - $46,922	909 Added 1.04%	88,014 $4.28 Million
Q3 2020 Nov 04, 2020	BUY	$49.47 - $53.77 $45,166 - $49,092	913 Added 1.06%	87,105 $4.37 Million
Q2 2020 Jul 17, 2020	BUY	$42.91 - $52.5 $225,534 - $275,940	5,256 Added 6.49%	86,192 $4.4 Million
Q1 2020 Apr 21, 2020	SELL	$38.02 - $51.66 $296,403 - $402,741	-7,796 Reduced 8.79%	80,936 $3.54 Million
Q4 2019 Feb 12, 2020	SELL	$44.25 - $50.86 $162,884 - $187,215	-3,681 Reduced 3.98%	88,732 $4.45 Million
Q3 2019 Nov 07, 2019	BUY	$40.34 - $46.64 $21,259 - $24,579	527 Added 0.57%	92,413 $4.28 Million
Q2 2019 Aug 06, 2019	SELL	$40.43 - $44.3 $465,874 - $510,468	-11,523 Reduced 11.14%	91,886 $3.98 Million
Q1 2019 May 06, 2019	BUY	$40.83 - $45.43 $249,675 - $277,804	6,115 Added 6.29%	103,409 $4.58 Million
Q4 2018 Feb 11, 2019	SELL	$41.48 - $45.59 $130,910 - $143,882	-3,156 Reduced 3.14%	97,294 $4.22 Million
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $48,240 - $54,077	-1,206 Reduced 1.19%	100,450 $4.49 Million
Q2 2018 Jul 30, 2018	BUY	$37.63 - $41.22 $364,032 - $398,762	9,674 Added 10.52%	101,656 $4.07 Million
Q1 2018 Apr 16, 2018	SELL	$38.98 - $45.76 $346,064 - $406,257	-8,878 Reduced 8.8%	91,982 $3.69 Million
Q4 2017 Feb 09, 2018	BUY	$42.86 - $50.61 $1.3 Million - $1.53 Million	30,280 Added 42.9%	100,860 $4.34 Million
Q3 2017 Oct 26, 2017	SELL	$47.04 - $50.34 $59,411 - $63,579	-1,263 Reduced 1.76%	70,580 $3.51 Million
Q2 2017 Aug 15, 2017	BUY	N/A	71,843	71,843 $3.44 Million

Others Institutions Holding SNY

# of Institutions

828

Shares Held

260M

Call Options Held

1.75M

Put Options Held

1.6M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Sanofi Transaction History